STAAR Surgical Company (STAA) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $20.82 (-1.98%), Market cap $1.63B, 52-week low–high $16.10 ~ $33.05.
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales represent
Financial statements, price targets, institutional (13F) holdings and related news for STAAR Surgical Company are updated in real time on BlackAll Trade.
STAAR Surgical Company trades at $20.82 (-1.98%). Real-time quotes and charts are available on BlackAll Trade.
STAAR Surgical Company has a market cap of about $1.63B.
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the e